Enhanced General Purpose Centrifuge Product Line Increases Capacity and Flexibility
New enhanced general purpose centrifuge product line offers clinical and life science researchers the ability to spin more samples in a single run while maximizing critical lab space.
The Thermo Scientific general purpose centrifuges feature increased capacity and flexibility with rotor innovations including the new Thermo Scientific TX-1000 rotor, which is the only rotor on the market that employs a 4-L capacity in a traditional 3-L footprint. In addition, the new Thermo Scientific MicroClick 30 x 2 rotor offers a 30-place capacity for microtube and nucleic acid spin columns, and is ideal for molecular biology applications. These high-capacity rotors are designed to process more tubes in fewer runs, saving time while reducing energy and wear on the centrifuge.
“Clinical and life science researchers using a general purpose centrifuge are always looking to save time, space and money while increasing productivity,” said Maurizio Merli, global product director, centrifugation, for Thermo Fisher Scientific. “Our latest rotor innovations address researchers’ needs by allowing them to spin more samples in one run for increased production without surrendering space, performance or flexibility.”
The Thermo Scientific general purpose centrifuge line is designed for a wide range of clinical and life science applications, from cell culture to bioproduction to proteomics, food safety, pharmaceutical, stem cell, microbiology and genomics. The general purpose centrifuge floor models conserve valuable bench space with an almost 25% smaller footprint compared to refrigerated benchtop models and a working height of 79 cm, providing true ergonomic design for removing tubes and exchanging rotors.
The new rotor innovations in the general purpose centrifuge line offer a number of features and benefits:
• TX-1000 rotor: • Up to 40 X 50 mL conical tubes, 196 blood tubes or 24 microplates
• Advanced lubricant and corrosion resistant coating
• Dual-purpose large bucket design accepts adapters for tubes or microplates
• MicroClick 30 x 2 rotor: • High 30-place volume for 1.5/2.0 mL microtube and nucleic acid spin columns
• ClickSeal biocontainment lid for quick and easy sample access.
Related News
-
News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel
A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to... -
News Protecting life-saving therapies: CPHI Online Podcast Series
The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.
-
News 2026 Outsourcing Outlook Update - pharma at a crossroads
The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ... -
News Roche maintains German investment commitment whilst rivals scale back
Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.
-
News Women in Pharma: The History of CPHI Women in Japan
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News EU drafts deal to end essential medicines shortage
European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.
-
News Thermo Fisher Scientific offloads microbiology business to PE firm Astorg
The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th... -
News The Shift: Why Sustainability is Moving to the Centre of CPHI Milan 2026
CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry.